【摘 要】
：
Objective The intercountry border areas of Myanmar and China have high malaria receptivity and vulnerability that present numerous problems in the control of malaria transmission.This study focused on
【机 构】
：
Institute of Tropical Medicine, Third Military Medical University, Chongqing, China
【出 处】
：
中华医学会第六次全国艾滋病、病毒性丙型肝炎暨全国热带病学术会议
论文部分内容阅读
Objective The intercountry border areas of Myanmar and China have high malaria receptivity and vulnerability that present numerous problems in the control of malaria transmission.This study focused on the Kachin state of Myanmar situated next to China.The purpose of the present study was to describe pattern and trend of malaria incidence in the highly endemic area along the Myanmar borders.Methods An epidemiological survey was conducted from Apr.2011 to Oct.2012 in 13 clinics or hospitals surrounding Laiza, Kachin on the border area of Myanmar and China.The clinically visiting patients with fever were considered to be involved in this study.
其他文献
Objectives To describe hematological adverse events (AE) and explore predictors for dose reduction caused by hematological AE in patients with advanced fibrosis receiving pegylated interferon plus rib
Background and aims Chronic hepatitis C (CHC) is a progressive fibrotic disease and not an inflammatory hepatitis.IL-22 is found to play a role in fibrogenesis in mice via hepatic stellete cells.Howev
Objectives To describe hematological adverse events (AE) and explore predictors for dose reduction caused by hematological AE in patients with advanced fibrosis receiving pegylated interferon plus rib
Background & Aims Non-alcoholic Fatty Liver Diseases (NAFLD), especially its critical stage of nonalcoholic steatohepatitis (NASH), has become one of the most important public health issues worldwide.
中国病毒性肝炎病人的住院收入增长是由于出院人次的增加,其中城市医院出院人数占70％强,以15-44岁年龄段人最好发,其次是45-59岁人群;2011年全国病毒性肝炎病高发地有青海、新疆和甘肃.应做好病毒性肝炎的健康教育、预防控制措施,扩大免疫规划工作,引导居民养成健康生活方式,有效遏制病毒性肝炎的发生和流行.
丙型肝炎近年来逐渐增多,已经成为人们关注的问题,我们运用中医辩证施治丙型肝炎.目的 是观察中医中药辩证治疗丙肝的疗效.方法 采用中药活血解毒为主兼结合降酶治疗并中医辩证论治的方法.结果 治疗前后临床症状有多改善.结论 中医中药辩证治疗结合中药活血化瘀对丙型肝炎效果满意.
目的 评价粒细胞集落刺激因子(G-CSF)联合聚乙二醇干扰素α-2b (PegIFNα-2b)、利巴韦林治疗中性粒细胞绝对值≤1.00×109/L丙肝肝硬化代偿期患者的有效性、安全性.方法 24例中性粒细胞绝对值≤1.00×109/L丙肝肝硬化代偿期患者,予皮下注射PegIFNα-2b 80 μg/周(体重＜60 kg,剂量为50μg/周)和口服利巴韦林(300 mg,3次/d),应用PegIFN
肝衰竭并发败血症、腹膜炎并不少见,但同时并发脑膜脑炎的则不多见,而由李斯特菌所致则罕见.我院近5年细菌培养前4位的细菌分别是:革兰氏阴性菌为大肠埃希菌、肺炎克雷伯杆菌、铜绿假单胞菌及鲍曼不动杆菌,革兰氏阳性菌为粪肠球菌、表皮葡萄球菌、屎肠球菌及溶血性葡萄球菌,和国内的相关报道基本一致,近十年未培养出李斯特菌.本例为慢性乙型病毒性肝炎患者,病程中曾不规则应用激素、抗生素、抗病毒药及中药,导致患者肝功
目的 血吸虫病是一种严重威胁人类生命健康的寄生虫病.血吸虫虫卵引起的肝脏肉芽肿和纤维化病变是导致血吸虫病患者死亡的主要原因,但目前血吸虫性肝纤维化发生的细胞和分子机制仍不清楚.以往研究已表明microRNA (miRNA)在多种人类疾病的发生发展中发挥重要的调控作用,但miRNA在血吸虫性肝病中的作用仍未见报道.本研究旨在探讨miRNA在血吸虫性肝病发生发展中的功能.
目的 研究神经梅毒(Neurosyphilis,NS)临床表现和诊断治疗的方法.方法 回顾性分析北京协和医院自1999年1月至2012年5月间住院期间确诊的37例NS患者的临床资料.结果 我院确诊NS的病例数为:1999-2005年共诊断4例,2006年-2012年确诊NS的病例数目较2005年以前呈显著升高,共32例.确诊病例中发病年龄中位数45 (27-71)岁,男女比例为2.4∶1.其中3例